Biologic activity of spores and dried powder from Ganoderma lucidum for the inhibition of highly invasive human breast and prostate cancer cells

Journal of Alternative and Complementary Medicine

Volumn 9, Issue 4, 2003, Pages 491-497

  Sliva, Daniel ^a,b   Sedlak, Miroslav ^c   Slivova, Veronika ^a   Valachovicova, Tatiana ^a   Lloyd Jr , Frank P ^a,b   Ho, Nancy W Y ^c  

^a METHODIST RESEARCH INSTITUTE   (United States)

^b INDIANA UNIVERSITY   (United States)

^c PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL ACETYLTRANSFERASE; DNA; GANODERMA LUCIDUM EXTRACT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PLANT EXTRACT;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CELL MIGRATION; CONTROLLED STUDY; DNA TRANSFECTION; ENZYME ASSAY; FEMALE; HERBAL MEDICINE; HUMAN; HUMAN CELL; MALE; NONHUMAN; POWDER; PRIORITY JOURNAL; PROSTATE CANCER; REPORTER GENE; TRADITIONAL MEDICINE;

EID: 0041358750     PISSN: 10755535     EISSN: None     Source Type: Journal    
DOI: 10.1089/107555303322284776     Document Type: Article

References (28)

1. Adams J. Preclinical and clinical evaluation of proteosome inhibitor PS-341 for the treatment of cancer. Curr Opin Chem Biol 2002;6:493-500.
2. de la Taille A, Hayek O, Buttyan R, Bagiella B, Burchardt M, Katz AE. Effects of PC-SPES in prostate cancer patient: A preliminary investigation in human cell lines and patients. Br J Urol 1999;84:845-850.
3. de la Taille A, Hayek OR, Burchardt M, Burchardt T, Katz AE. Role of herbal compounds (PC-SPES) in hormone-refractory prostate cancer: Two case reports. J Altern Complement Med 2000a;6:449-451.
4. de la Taille A, Buttyan R, Hayek O, Bagiella E, Shabsigh A, Burchardt M, Burchardt T, Chopin DK, Katz AE. Herbal therapy PC-SPES: In vitro effects and evaluation of its efficacy in 69 patients with prostate cancer. J Urol 2000b;164:1229-1234.
5. DiPaola RS, Zhang H, Lambert GH, Meeker R, Licitra E, Rafi MM, Zhu BT, Spaulding H, Goodin S, Toledano MB, Hait WN, Gallo MA. Clinical and biologic activity of an estrogenic herbal combination (PC-SPES) in prostate cancer. N Engl J Med 1998;339:785-787.
6. Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, Kessler RC. Trends in alternative medicine use in the United States, 1990-1997: Results of a follow-up national survey. JAMA 1998;280:1569-1575.
7. Hsieh TC, Wu JM. Mechanism of action of herbal supplement PC-SPES: Elucidation of effects of individual herbs of PC-SPES on proliferation and prostate specific gene expression in androgen-dependent LNCaP cells. Int J Oncol 2002;20:583-588.
8. Ikeda K, Arao Y, Otsuka H, Nomoto S, Horiguchi H, Kato S, Kaymana F. Terpenoids found in the umbelliferae family act as agonists/antagonists for ERα and ERβ: Differential transcription activity between ferutinine liganded ERα and ERβ. Biochem Biophys Res Commun 2002:291;354-360.
9. Kuiper GGJM, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson J-Å. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β. Endocrinology 1998;139:4252-4263.
10. Lau KM, LaSapina M, Long J, Ho SM. Expression of estrogen receptor (ER)-α and ER-β in normal and malignant prostatic epithelial cells: Regulation by methylation and involvement in growth regulation. Cancer Res 2000;60:3175-3182.
11. Liu X, Yuan JP, Chung CK, Cen XJ. Antitumor activity of the sporoderm-broken germinating spores of Ganoderma lucidum. Cancer Lett 2002;82:155-161.
12. Ludes-Meyers JH, Liu Y, Munoz-Medellin D, Hilsenbeck SG, Brown PH. AP-1 blockade inhibits the growth of normal and malignant breast cells. Oncogene 2001;20:2771-2780.
13. Mazar AP. The urokinase plasminogen activator receptor (uPAR) as a target for the diagnosis and therapy of cancer. Anticancer Drugs 2001;12:387-400.
14. Min BS, Gao JJ, Nakamura N, Hattori M. Triterpenes from the spores of Ganoderma lucidum and their cytotoxicity against meth-A and LLC tumor cells. Chem Pharm Bull 2000;48:1026-1033.
15. Miyazaki T, Nishijima M. Studies on fungal polysaccharides. XXVII. Structural examination of a water-soluble, antitumor polysaccharide of Ganoderma lucidum. Chem Pharm Bull 1981;29:3611-3616.
16. Pfeifer BL, Pirani JF, Hamann SR, Klippel KF. PC-SPES, a dietary-supplement for the treatment of hormone refractory cancer. BJU Int 2000;85:481-485.
17. Price JT, Bonovich MT, Kohn EC. The biochemistry of cancer dissemination. Crit Rev Biochem Mol Biol 1997;32:175-253.
18. Sliva D, Labarrere C, Slivova V, Sedlak M, Lloyd FP Jr, Ho NWY. Ganoderma lucidum suppresses motility of highly invasive breast and prostate cancer cells. Biochem Biophys Res Commun 2002a;298:603-612.
19. Sliva D, Rizzo MT, English D. Phosphatidylinositol 3-kinase and NF-κB regulate motility of invasive MDA-MB-231 human breast cancer cells by the secretion of urokinase-type plasminogen activator. J Biol Chem 2002b;277:3150-3157.
20. Small EJ, Frohlich MW, Bok R, Shinohara K, Grossfeld G, Rozenblat Z, Kelly WK, Corry M, Reese DM. Prospective trial of the herbal supplement PC-SPES in patients with progressive prostate cancer. J Clin Oncol 2000;18:3595-3603.
21. Sone Y, Okuda R, Wada N, Kishida E, Misaki A. Structures and antitumor activities of the polysaccharides isolated from fruiting body and the growing culture of mycelium of Ganoderma Lucidum. Agric Biol Chem 1985;49:2641-2653.
22. Sovak M, Selingson AL, Konas M, Hajduch M, Dolezal M, Machala M, Nagourney R. Herbal composition PC-SPES for management of prostate cancer: Identification of active principles. J Natl Cancer Inst 2002;94:1275-1281.
23. Tong D, Schuster E, Seifert M, Czerwenka K, Leodolter S, Zeillinger R. Expression of estrogen receptor beta isoforms in human breast cancer tissues and cell lines. Breast Cancer Res Treat 2002;71:249-255.
24. Wang CY, Cusack JC Jr, Liu R, Baldwin AS Jr. Control of inducible chemoresistance: Enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-κB. Nature Med 1999;5:412-417.
25. Wang SY, Hsu ML, Hsu HC, Lee SS, Shiao MS, Ho CK. The anti-tumor effect of Ganoderma lucidum is mediated by cytokines released from activated macrophages and T lymphocytes. Int J Cancer 1997;70:699-705.
26. White J. PC-SPES-A lesson for future dietary supplement research. J Natl Cancer Inst 2002;94:1261-1263.
27. Wilasrumee C, Kittur S, Siddiqui J, Bruch D, Wilasrumee S, Kittur DS. In vitro immunomodulatory effects of ten commonly used herbs on murine lymphocytes. J Altern Complement Med 2002;8:467-475.
28. Zhang J, Tang Q, Zimmerman-Kordmann, Reutter W, Fan H. Activation of B lymphocytes by GLIS. A bioactive proteoglycan from Ganoderma lucidum. Life Sci 2002;71:623-638.